CME Group Inc. $CME Stock: Resona Asset Management Co. Ltd. Reduces Position

Resona Asset Management Co. Ltd. cut its position in CME Group Inc. (NASDAQ:CME – Free Report) by 4.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 118,671 shares of the financial services provider’s stock after selling 5,352 shares during the period. Resona Asset Management Co. Ltd.’s holdings in CME Group were worth $31,117,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of CME. E Fund Management Hong Kong Co. Ltd. boosted its holdings in shares of CME Group by 7,833.3% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 238 shares of the financial services provider’s stock valued at $62,000 after acquiring an additional 235 shares during the last quarter. Sumitomo Life Insurance Co. increased its stake in shares of CME Group by 2.3% in the third quarter. Sumitomo Life Insurance Co. now owns 56,333 shares of the financial services provider’s stock worth $14,758,000 after acquiring an additional 1,268 shares during the period. Mayflower Financial Advisors LLC raised its holdings in shares of CME Group by 0.7% during the third quarter. Mayflower Financial Advisors LLC now owns 8,042 shares of the financial services provider’s stock worth $2,107,000 after purchasing an additional 55 shares during the last quarter. Advisors Asset Management Inc. purchased a new position in shares of CME Group during the third quarter worth $1,675,000. Finally, GW&K Investment Management LLC raised its holdings in shares of CME Group by 8.1% during the third quarter. GW&K Investment Management LLC now owns 545 shares of the financial services provider’s stock worth $143,000 after purchasing an additional 41 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on CME shares. Weiss Ratings upgraded CME Group from a “buy (b)” rating to a “buy (b+)” rating in a research note on Friday, November 13th. Deutsche Bank cut CME Group from a “buy” rating to a “hold” rating and decreased their price objective for the company from $286.00 to $270.00 in a report on Wednesday, August 19th. CLSA set a $367.00 target price on CME Group in a research note on Thursday, October 22nd. TD Cowen raised their target price on CME Group from $292.00 to $300.00 and gave the stock a “buy” rating in a report on Monday, October 5th. Finally, Wells Fargo & Company raised their target price on CME Group from $315.00 to $333.00 and gave the stock an “overweight” rating in a report on Thursday, October 22nd. Ten research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $314.44.

Check Out Our Latest Research Report on CME

CME Group Stock Performance

NASDAQ:CME opened at $307.54 on Friday. The company has a market cap of $110.08 billion, a P/E ratio of 25.23, a P/E/G ratio of 3.75 and a beta of 0.15. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The company’s 50-day moving average price is $289.43 and its 200-day moving average price is $282.08. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings data on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.99 by $0.03. CME Group had a net margin of 63.33% and a return on equity of 16.23%. The company had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.71 billion. During the same quarter in the prior year, the company earned $2.68 EPS. CME Group’s revenue was up 10.6% compared to the same quarter last year. On average, sell-side analysts forecast that CME Group Inc. will post 12.36 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 11th will be issued a dividend of $1.30 per share. The ex-dividend date is Friday, December 11th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. CME Group’s dividend payout ratio (DPR) is currently 42.66%.

Insider Buying and Selling at CME Group

In related news, Director Daniel G. Kaye sold 532 shares of the stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $304.17, for a total value of $161,818.44. Following the completion of the transaction, the director directly owned 4,313 shares in the company, valued at approximately $1,311,885.21. This represents a 10.98% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Julie Winkler sold 10,079 shares of the stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $305.15, for a total value of $3,075,606.85. Following the completion of the transaction, the insider owned 21,482 shares of the company’s stock, valued at $6,555,232.30. The trade was a 31.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 61,166 shares of company stock worth $18,276,512. Insiders own 0.30% of the company’s stock.

Key Stories Impacting CME Group

These are some of the CME stories that stood out recently:

  • Positive Sentiment: CME’s latest reported quarter beat analyst expectations: earnings were $3.02 per share versus a $2.99 consensus, while revenue of $1.74 billion exceeded estimates and grew 10.6% year over year. Article
  • Neutral Sentiment: A report highlights exchange operators’ potential exposure to AI-driven trading, but provides no specific new CME business or financial update. Article
  • Negative Sentiment: CEO Terrence Duffy sold 27,000 shares, reducing his direct holdings by about 43%; General Counsel John Marchese also sold 655 shares. Insider sales can be for personal reasons and do not necessarily signal weaker prospects, but may weigh on sentiment. CEO sale report General counsel sale report

About CME Group

(Free Report)

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.

Recommended Stories

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.